Estrog-100™ Clinical Study Extracts
The Effect of Herbal Extract (EstroG-100™) on Pre-, Peri- and Post-Menopausal Women: A Randomized Double-blind, Placebo-controlled Study
Evaluation of Effectiveness and Safety of Natural Plants Extract (Estromon®) on Perimenopausal Women for 1 Year
Proven to alleviate 10 of the 12 main symptoms of menopause
Enzogenol® Clinical Studies
Enzogenol® has been through two randomised controlled nutrition trials at Auckland University of Technology and the Brain Sciences Institute at Swinburne University in Melbourne.
Links to trials
- 1. Theodom et al. 2013, European J of Neurology – https://pubmed.ncbi.nlm.nih.gov/23384428/
- 2. Pipingas et al. 2008, Phytotherapy Research – https://pubmed.ncbi.nlm.nih.gov/18683195/
- Improved cognitive performance after dietary supplementation with a Pinus radiata bark extract Formulation – https://onlinelibrary.wiley.com/doi/abs/10.1002/ptr.2388
Chemical Composition
MENOME GLOSSARY
EstroG-100™
EstroG-100™ is a proprietary standardized novel phytoestrogen.
It was screened out of 71 different herbal extracts through e-testing. Out of these, three extracts were chosen to make up the blend: cynanchum wilfordii, phlomis umbrosa, and angelica gigas nakai.
400 Hundred Years Of History
Together, these tree herbal root extracts make up EstroG-100™. They have a rich history in Asia with 400 years of documented use in Korea and China as folk medicine. Their proven safety record has seen them registered as safe food ingredients in the Korean food codex and in China.
Quality of Life
Scientific testing demonstrated that EstroG-100™ significantly improved at least 10 different symptoms of perimenopause and menopause, including hot flushes, paresthesia, nervousness, melancholia, vertigo, fatigue, rheumatic pain, formication and vaginal dryness.
No severe adverse effects or change of body weight were reported along with an improvement on the Kupperman Menopause Index which measures quality of life.
Increased Bone Density
Another positive benefit included an increase in bone mass density when taking EstroG-100™ for 12 weeks.
Clinical studies show that EstroG-100™ has no estrogenic effect and, unlike hormone replacement therapy, it does not affect weight or body mass index.